Effect of Bronchiectasis on Respiratory Functions, Exercise Capacity, Dyspnea Perception and Quality of Life in COPD Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bronchiectasis
- Sponsor
- Izmir Katip Celebi University
- Enrollment
- 35
- Primary Endpoint
- Exercise capacity
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The etiology of bronchiectasis, known as permanent, abnormal, and localized development of bronchi, varies. However, most of them are responsible for infections during childhood. The prevalence of bronchiectasis is particularly high in advanced COPD patients. This phenomenon, called COPD-bronchiectasis overlap syndrome, affects the clinic of COPD patients negatively. In this study; bronchiectasis in respiratory function, exercise capacity, dyspnoea and quality of life in COPD patients.
Detailed Description
The etiology of bronchiectasis, known as permanent, abnormal, and localized development of bronchi, varies. However, most of them are responsible for infections during childhood. The prevalence of bronchiectasis is particularly high in advanced COPD patients. This phenomenon, called COPD-bronchiectasis overlap syndrome, affects the clinic of COPD patients negatively. In this study; bronchiectasis in respiratory function, exercise capacity, dyspnoea and quality of life in COPD patients. Torax CTs of patients with COPD who are admitted to the outpatient clinic will be examined. There will be two groups, group 1 in patients with COPD accompanied by bronchiectasis and group 2 in COPD patients without bronchiectasis. In both groups, respiratory function tests, exercise capacities, dyspnea perceptions and quality of life will be evaluated. The data will be compared between the two groups.
Investigators
Ilknur Naz
Asst. Prof.
Izmir Katip Celebi University
Eligibility Criteria
Inclusion Criteria
- •above 18 years old
- •clinically stable
Exclusion Criteria
- •other respiratory disease
Outcomes
Primary Outcomes
Exercise capacity
Time Frame: 15 minutes
six minute walk test
Secondary Outcomes
- Dyspnea Severity(5 minutes)
- Lung Function(20 minutes)
- Health Related Quality of Life(25 minutes)